Schedule 13G ownership disclosure
Biopharmx
Security class unavailable · CUSIP: 09072X101
Event date: 2017-04-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,846,154
- Percent of class
- 5.1900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-17-002105
- Form type
- SC 13G
- Filer
- BioPharmX Corp
- CIK
- CIK 1504167
- Filed
- May 01, 2017
- Reporting period
- Apr 26, 2017
- Description
- Schedule 13G beneficial ownership